Chimo is a private monitoring and filing service and is not the court, the settlement administrator or a law firm.

The claim deadline passed on May 15, 2026. New claims for this settlement are no longer being accepted.
The court held its approval hearing on May 5, 2026. That was the final approval hearing, where a judge decides whether to approve the settlement. Nothing is paid out until that approval is final.
Payments come after approval, and after any appeals. Anyone who objected to the settlement can ask a higher court to look at it again — an appeal — and that has to finish first. Eligible payments are sent once approval is final, and the stretch from a claim deadline to money in hand often runs a year or more. It varies from one settlement to the next.
Filed this claim with Chimo? The status of your claim is on the claims page in your account.


Consumers sued Premier Nutrition Company, LLC, saying it falsely advertised its Joint Juice glucosamine supplements. According to the lawsuits, the company marketed the products as helping lubricate joints, support cartilage, and improve joint comfort despite scientific evidence allegedly showing glucosamine and chondroitin did not provide the promised benefits. Premier Nutrition denies that it did anything wrong, and the court has not decided the case in favor of either side.
The Joint Juice Supplements legal claims were filed beginning in 2013, with California plaintiff Patricia Bland filing in 2019 (Case No. RG19002714) in the Superior Court of California, County of Alameda. Related actions were brought by Kathleen Sonner and other plaintiffs across multiple states. The litigation spanned more than 12 years, including federal proceedings and a New York jury verdict, before reaching a $90 million global resolution in 2025.
The multi-state settlement created a $70.8 million fund for consumers in eight states. A separate New York action (Montera v. Premier Nutrition), in which the court awarded statutory damages of $50 per unit after the jury verdict, has its own settlement and claim form for New York buyers. Settlement documents include the Stipulation of Settlement and Preliminary Approval Order entered by the court.
The Joint Juice Supplements settlement created a $70,839,813.53 multi-state fund resolving claims that Premier Nutrition falsely advertised the joint health benefits of its glucosamine products. The Joint Juice Supplements lawsuit settlement amount is part of a broader $90 million resolution reached after more than 12 years of litigation, multiple appeals, and a New York jury verdict.
The settlement followed extensive discovery, including over 500,000 pages of documents, more than 60 depositions, expert testimony, and sessions before six mediators. After trial proceedings and appellate rulings increased risk for both sides, the parties accepted a mediator’s proposal to avoid further years of litigation and uncertainty.
Under the Joint Juice Supplements settlement eligibility terms, consumers who purchased in CA, CT, FL, IL, MD, MA, MI, or PA between 2009 and December 31, 2022, could receive $10 or $25 per unit, depending on product type. No proof was required for up to six units, and class members identified from major retailers' records were to be paid automatically without filing. The fund is non-reversionary, meaning no money returns to the company. The claim deadline was May 15, 2026. New claims can no longer be filed.
How much could an eligible class member claim from the Joint Juice Supplements settlement? The per-unit amounts were set around estimated retail pricing during the class periods. According to the plaintiffs' preliminary approval motion, the $10 and $25 per-unit tiers were at least 150% of the average retail price paid for smaller and larger package formats.
Eligible class members could receive between $10 and $25 per unit, based on product type and number of units claimed. The notice said the actual amount could be adjusted up or down depending on how many claims were filed.
The six-unit no-proof limit was negotiated as a balance between consumer accessibility and fraud prevention. It let eligible class members claim up to six units, worth up to $150, without receipts, while requiring documentation for higher-volume claims to protect the integrity of the $70,839,813.53 non-reversionary fund.
The court granted final approval on May 26, 2026. Payments are made to eligible claimants after claim verification and any appeals, and the notice warned that an appeal could take more than a year.
To qualify for the Joint Juice Supplements class action settlement, people had to have purchased Joint Juice in CA, CT, FL, IL, MD, MA, MI, or PA during state-specific periods ending December 31, 2022.
The claim form asked where you made the purchase, because the state determined class membership.
It asked when you made the purchase, because the date had to fall within the certified class dates.
It asked which product type you bought: a 6-pack, 30-pack, Easy Shot, or powder.
It asked how many units you bought. No proof was required for up to six.
It asked whether you received a retailer notice, which identified direct payment members.
Courts required state-by-state class certification, which is why location mattered. Retailer records from Costco, Walmart, Sam’s Club, and Amazon were subpoenaed—covering over 80% of sales—to identify class members for automatic payments.
The litigation involved federal and state courts, multiple appeals, class certification fights in nine states, a New York jury trial, and even a U.S. Supreme Court petition.
The New York action (Montera) went to a full jury verdict. After the jury found for the New York class, the court awarded statutory damages of $50 per unit under New York law, more than the per-unit amounts in this settlement.
According to the plaintiffs' preliminary approval motion, the per-unit amounts were at least 150% of the average retail price paid during the class periods, and they were to be increased as needed to distribute the whole net fund to class members.
Premier Nutrition cannot recover leftover funds. Any remaining money goes to the Rheumatology Research Foundation, not back to the company.
Retailer records from these stores covered over 80% of sales and were subpoenaed to identify automatic payment recipients.
Plaintiffs argued that glucosamine hydrochloride and chondroitin did not provide the joint health benefits advertised.
No. The company denies liability but agreed to settle to avoid further litigation risk and expense. The court has not decided the case in favor of either side.
Yes. The notice said the actual amount could be adjusted up or down depending on how many claims were filed, and the plaintiffs' motion said per-unit awards would be increased as needed to distribute the whole net fund.
These are the court's own records for this case. They are hosted here unchanged, so you can check anything on this page against the documents themselves.
Chimo AI Inc. is a private company. We are not a law firm, do not give legal advice, and are not affiliated with or endorsed by any court, settlement administrator, defendant or government agency.